Topical Insulin Drops for Glaucoma Treatment
Part of Eyes & vision clinical trials.
This study tests whether insulin eye drops applied directly to the eye can help slow or stop glaucoma progression. Glaucoma damages the optic nerve and causes vision loss; this trial explores whether insulin might protect the nerve and preserve sight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Diagnosed with glaucoma
- Not pregnant or breastfeeding
- No diabetes (type 1 or type 2) or blood sugar disorders
- No other serious eye diseases besides glaucoma that cause vision loss
- Able to complete eye tests reliably and attend all follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an eye drop (G01) for people with primary open-angle glaucoma that is getting worse despite current treatments. It aims to see if G01 can safely slow down or stop the progression of glaucoma.
This study tests a new eye drop medicine (DNN.31.19.026) to lower pressure inside the eye for people with glaucoma or ocular hypertension. The goal is to see if it works safely when combined with other eye pressure medications.
This study checks whether a device called the Nanodropper helps deliver glaucoma medicine as well as standard use. It is for adults with stable primary open-angle glaucoma (or ocular hypertension) who are on a limited number of eye-pressure medicines.
This study looks at how certain glaucoma eye drops affect the surface of your eye. It tests a new implant that may reduce damage and improve comfort.
This study is looking at people with glaucoma or high eye pressure who are about to have glaucoma surgery. The goal is to understand more about their condition and how it responds after stopping their usual eye drops for a short time before surgery.
This Phase 1 study tests an insulin-based eye treatment to see if it’s safe and potentially helpful for people with glaucoma-related optic nerve damage. If you may be eligible, you’ll have a close eye exam and repeated vision testing, mainly focused on one study eye.
Hear when a new Primary Open Angle Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.